Frank Vinluan from MedCity News - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation		3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - 3 days ago Sanofi Jumps Into Radiopharmaceuticals, Paying €100M for Therapy That Could Rival a Novartis Drug - 4 days ago SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition - 5 days ago Bayer Asset Gives Roivant Sciences’ New ‘Vant’ a Shot at Besting a United Therapeutics Lung Drug - 6 days ago Terns Pharma Oral GLP-1 Drug Leads to Greater Than 5% Weight Loss in Small Study - 7 days ago A Biotech Going Through the Nose to Treat the Brain Plots Alternative Path to Public Markets - 8 days ago Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas - 10 days ago Eli Lilly Moves Closer to Bringing Diabetes Patients a Once-Weekly Insulin Alternative - 11 days ago With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and PBMs - 12 days ago Illumina’s European Court Victory Can’t Salvage Grail Acquisition, But It Nullifies Hefty Fine - 13 days ago Highly Anticipated FDA Decision Comes Just in Time for Back-to-School Season - 14 days ago FDA Approves Emergent BioSolutions Vaccine as New Tool in Fight Against Mpox - 17 days ago Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline - 18 days ago FDA Rejection Delays Regeneron From Competing With J&J, Pfizer in Multiple Myeloma - 26 days ago Eli Lilly Drug Reduces Risk of Diabetes Onset, Building Case for Broader Use of the Therapy - 27 days ago Digital Therapeutics Sector Sees Billing Codes as Key to Breaking Free of Reimbursement Rut - 28 days ago FDA Authorizes First At-Home, OTC Diagnostic Test for Syphilis - 29 days ago Pfizer, BioNTech Flu and Covid-19 Combo Vaccine Falls Short Against Influenza B Strain - about 1 month ago CMS Touts First Negotiated Drug Prices, But Greater Impact Expected in Future Rounds - about 1 month ago FDA Awards Accelerated Approval to Gilead Sciences Drug for Rare Liver Disease - about 1 month ago Private Equity Buys Another Piece of Baxter as Carlyle Scoops Up Kidney Care Biz for $3.8B - about 1 month ago Ascendis Pharma Lands Long-Awaited FDA Drug Approval in Rare Hormone Deficiency - about 1 month ago Merck Picks Up Novel Bispecific Antibody With Potential in Both Cancer & Autoimmune Disease - about 1 month ago Path Forward for Cancer Biotech G1 Therapeutics Is $405M Acquisition by Pharmacosmos - about 1 month ago Big Servier Acquisition Pays Off as FDA Approves Drug for Two Types of Rare Brain Cancer - about 1 month ago Startup Red Queen Therapeutics Unveils $55M and Tech to Defeat Elusive Viral Pathogens - about 1 month ago Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors - about 1 month ago Otsuka Commits $800M in M&A Deal Bringing a Phase 3-Ready Metabolic Disorder Drug - about 2 months ago Biotech Startup AIRNA Adds $60M to Advance RNA-Editing Therapy for Rare Protein Deficiency - about 2 months ago With FDA Nod for Colorectal Cancer Screening, How Much Market Share Can Guardant’s Blood Test Get? - about 2 months ago GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines - about 2 months ago Pfizer Hemophilia Gene Therapy Meets Phase 3 Goals, But Its Success Matters More to Sangamo - about 2 months ago Flagship Pioneering Launches Startup Abiologics to Advance New Class of Biologic Drugs - about 2 months ago Neuro Drug Passed Up by Biogen Posts Positive Data for Ionis, Setting Stage for Phase 3 Test - about 2 months ago Artiva’s IPO Reels In $167M to Bring NK Cell Therapy to Autoimmune Diseases - about 2 months ago Aiming to Top Amgen in Gout, Startup GRObio Gets $60M to Enter the Clinic - about 2 months ago Roche Weighs In With Encouraging Early Clinical Data for Oral GLP-1 Drug - 2 months ago Tau-Focused Asceneuron Adds $100M as Oral Alzheimer’s Drug Advances to Phase 2 Trial - 2 months ago Positive Data in Pancreatic Cancer Pave Way for Pivotal Test of Revolution Medicines Drug - 2 months ago How Startup miRecule Leveraged Its RNA Platform Tech to Land a Sanofi Alliance - 2 months ago FDA Says ‘No’ to Novo Nordisk’s Once-Weekly Insulin - 2 months ago Ipsen Turns to China-Based Biotech to Get Another ADC Cancer Drug - 2 months ago Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think - 2 months ago Eli Lilly Shows Appetite for Oral Immunology Drugs, Swallowing Morphic in $3.2B Deal - 2 months ago Sanofi & Regeneron Drug Dupixent Gets EMA Approval as the First Biologic COPD Med - 2 months ago GSK Pays CureVac €400M to Pick Up Clinical-Stage mRNA Vaccines for Infectious Diseases - 2 months ago Eli Lilly Alzheimer’s Drug Lands FDA Approval, Introducing Competition to Eisai’s Leqembi - 3 months ago Moderna Gets $176M From BARDA for Key Test of Bird Flu Vaccine - 3 months ago Eli Lilly Puts $1B on the Line to Expand its Cancer Radiopharmaceuticals Prospects - 3 months ago Inflammation Biotech Alumis Trims IPO Plans But Still Raises $250M for Clinical Trials - 3 months ago